Feline herpesviral keratoconjunctivitis

Feline herpesviral keratoconjunctivitis is an inflammatory eye condition caused by feline herpesvirus type 1, affecting both the cornea and conjunctival tissues. This viral disease represents one of the most common and significant causes of ocular disease in cats worldwide, with the virus being ubiquitous in the feline population. Estimates suggest that 80-90% of all cats have been exposed to feline herpesvirus at some point in their lives, though not all develop clinical eye disease. The condition can affect cats of any age but is most severe in young kittens with immature immune systems and in immunocompromised adult cats.

Feline herpesvirus type 1 causes keratoconjunctivitis through direct viral infection and subsequent inflammation of ocular surface tissues. Following initial exposure, typically during kittenhood, the virus establishes a latent infection in nerve ganglia where it persists for the cat's lifetime. Periodic reactivation of the latent virus, often triggered by stress, illness, or immunosuppression, leads to recurrent episodes of active infection and clinical disease. The virus directly damages the corneal epithelium and triggers immune responses that contribute to tissue destruction and inflammation. This cycle of reactivation and immune response accounts for the characteristically relapsing-remitting nature of the condition.

The impact of herpesviral keratoconjunctivitis on feline health ranges from mild, self-limiting conjunctivitis to severe, sight-threatening corneal disease depending on the host immune response and viral factors. Acute infections cause significant discomfort, including pain, excessive tearing, and light sensitivity. Chronic or recurrent disease leads to progressive corneal damage including scarring, vascularization, and sequestrum formation that can permanently impair vision. Severe cases may result in corneal perforation and loss of the eye. Beyond the direct ocular effects, herpesvirus is highly contagious among cats, making affected individuals potential sources of infection for susceptible contacts.

Feline herpesviral keratoconjunctivitis is manageable but not curable, as the virus establishes lifelong latent infection. Treatment focuses on supporting the immune response, providing antiviral therapy during active episodes, and managing complications. Early intervention improves outcomes and reduces the severity of individual episodes. While the condition may recur throughout the cat's life, many cats experience decreasing episode frequency and severity with age as their immune systems become more adept at controlling viral reactivation. Veterinary care is essential for proper diagnosis and management, as the condition requires differentiation from other eye diseases and treatment must be tailored to the individual case.

The primary cause of feline herpesviral keratoconjunctivitis is infection with feline herpesvirus type 1, a double-stranded DNA virus belonging to the Herpesviridae family. This virus is specific to cats and does not infect humans or other animal species. Initial infection typically occurs during early life through direct contact with infected cats, exposure to respiratory secretions, or contaminated fomites such as food bowls, bedding, or human hands. Mother cats can transmit the virus to their kittens during nursing and grooming. The virus has a particular affinity for the tissues of the upper respiratory tract and ocular surface, where it causes the characteristic disease manifestations.

Genetic and hereditary factors do not cause feline herpesvirus infection but may influence disease susceptibility and severity. Individual variation in immune system function affects a cat's ability to control viral infection and limit tissue damage. Some cats appear to have more robust antiviral immunity, experiencing only mild disease despite exposure, while others develop severe and recurrent problems. No specific genes predisposing to herpesvirus susceptibility have been identified in cats, and breed predisposition has not been documented. However, inherited variations in immune response genes likely contribute to the wide spectrum of disease severity observed in infected cats.

Environmental and lifestyle factors significantly influence both initial infection risk and subsequent disease course. Cats living in crowded conditions such as shelters, catteries, and multi-cat households face dramatically increased exposure risk due to high population density and the ease of virus transmission. Stress from any source, including environmental changes, travel, boarding, surgery, or introduction of new household members, can trigger reactivation of latent virus. Poor nutrition, inadequate ventilation, and unsanitary conditions compromise immune function and facilitate virus transmission. Indoor cats in stable single-cat households generally have lower exposure risk and may experience less frequent reactivations than cats in more stressful environments.

Risk factors for developing herpesviral keratoconjunctivitis include young age at initial infection, immunosuppression from any cause, and concurrent illness. Kittens between two and twelve weeks of age are particularly vulnerable due to waning maternal immunity and immature immune systems. Cats infected with feline immunodeficiency virus or feline leukemia virus may experience more severe and persistent herpesvirus disease. Treatment with corticosteroids or other immunosuppressive medications can trigger viral reactivation and exacerbate clinical signs. Chronic stress, poor body condition, and concurrent systemic illness all increase susceptibility to active herpesviral eye disease.

The mechanism by which herpesviral keratoconjunctivitis develops involves both direct viral cytopathic effects and immune-mediated tissue damage. Upon infection, the virus invades conjunctival and corneal epithelial cells, replicating within them and causing cell death. This epithelial destruction creates the ulcerative lesions characteristic of herpes keratitis. The immune system responds with inflammatory cells and cytokines that, while aimed at controlling viral spread, contribute to tissue damage. Following acute infection, the virus travels along sensory nerves to establish latency in the trigeminal ganglia. Reactivation occurs when stress or immunosuppression allows the latent virus to resume replication and travel back to the eye. Repeated cycles of reactivation and healing lead to the progressive corneal changes seen in chronic cases.

Early warning signs of feline herpesviral keratoconjunctivitis often develop rapidly following exposure or reactivation of latent virus. Initial symptoms typically include increased tearing, squinting, and mild redness of the conjunctival tissues. Cats may blink more frequently than normal or hold the affected eye partially closed. Slight discharge, initially clear and watery, may be visible at the inner corner of the eye. Some cats show concurrent sneezing or mild nasal discharge, as the virus commonly affects both ocular and respiratory tissues simultaneously. These early signs may progress over one to several days to more obvious disease manifestations.

Common symptoms of established herpesviral keratoconjunctivitis become readily apparent as the infection progresses. Significant conjunctival swelling and redness develop, with the inner lining of the eyelids appearing angry and inflamed. Discharge typically becomes more copious and may transition from clear to cloudy or mucopurulent, especially if secondary bacterial infection occurs. The cornea may show visible abnormalities including cloudiness, irregularity, or the characteristic dendritic ulcer pattern that, while classic for herpes, is not always present. One or both eyes may be affected, and bilateral disease is common though often asymmetric in severity.

Behavioral changes in cats with herpesviral keratoconjunctivitis reflect the discomfort associated with active ocular disease. Affected cats often become less active and may hide or seek out quiet, dark areas to avoid light that aggravates their sensitive eyes. Appetite frequently decreases, particularly if nasal congestion affects the cat's ability to smell food. Some cats become more clingy and seek comfort from their owners, while others prefer solitude. Grooming behavior may decrease as cats feel unwell, though some may excessively paw at their faces in response to ocular irritation. Play behavior and normal activity levels typically decline during active episodes.

Physical signs observable during examination include the characteristic corneal lesions that distinguish herpesviral keratitis. Dendritic ulcers, so named for their branching tree-like pattern, represent a pathognomonic finding when present, though many cases show only geographic or irregular ulceration patterns. The cornea may appear hazy or edematous around areas of active infection. In chronic cases, blood vessels may be visible growing across the normally clear cornea, and areas of scarring or pigmentation may be present. The third eyelid often becomes more prominent and may show direct viral involvement. Fluorescein stain, applied during veterinary examination, highlights any areas of corneal epithelial loss.

Symptom progression in herpesviral keratoconjunctivitis follows variable courses depending on immune status and treatment. Uncomplicated cases in immunocompetent cats typically peak in severity at seven to fourteen days and then gradually resolve over an additional one to three weeks. Severe or immunocompromised cases may progress to deep corneal ulceration, stromal keratitis, or corneal sequestrum formation. Some cats develop chronic low-grade disease with persistent mild signs rather than discrete episodes. The characteristic relapsing-remitting pattern becomes established in carrier cats, with episodes occurring at variable intervals, often triggered by identifiable stressors. Without treatment, each recurrence may add to cumulative corneal damage.

Emergency symptoms requiring immediate veterinary attention include signs of severe or rapidly progressing corneal disease. Deep corneal ulceration, visible as a crater-like defect or intense cloudiness in the central cornea, requires urgent treatment to prevent perforation. Obvious rupture of the cornea, with fluid or pigmented tissue visible at the eye surface, is a surgical emergency. Severe pain evidenced by inability to open the eye, intense squinting, and extreme light sensitivity warrants emergency evaluation. Dramatic swelling of the conjunctiva to the point of protruding from between the eyelids indicates severe inflammation requiring immediate attention. Any sudden worsening in a cat with known herpesvirus disease should prompt urgent veterinary contact.

Initial examination for suspected feline herpesviral keratoconjunctivitis includes a thorough history and complete ophthalmic evaluation. The veterinarian will inquire about the duration and progression of symptoms, any known exposure to cats with respiratory or eye disease, recent stressful events, and the cat's vaccination history. Physical examination assesses vital signs, lymph node size, and the presence of concurrent upper respiratory signs. Ophthalmic examination evaluates both eyes, comparing them for asymmetric involvement. External examination notes discharge characteristics, eyelid position, and third eyelid appearance before detailed evaluation of the conjunctiva, cornea, and other ocular structures.

Diagnostic tests for herpesviral keratoconjunctivitis aim to characterize the ocular lesions and confirm viral etiology when possible. Fluorescein staining is essential for evaluating corneal integrity, revealing the characteristic dendritic or geographic ulceration patterns suggestive of herpes infection. Rose bengal staining may highlight early epithelial damage not visible with fluorescein alone. Schirmer tear testing assesses tear production, which may be reduced in chronic herpesvirus cases. Polymerase chain reaction testing of conjunctival swabs can detect viral DNA, providing definitive evidence of herpesvirus involvement, though false negatives can occur if viral shedding is intermittent and false positives may occur in latently infected cats without active disease.

Differential diagnosis for herpesviral keratoconjunctivitis includes other causes of feline conjunctivitis and keratitis. Chlamydophila felis infection causes conjunctivitis that may resemble mild herpesviral disease, though corneal involvement is less common. Mycoplasma conjunctivitis presents similarly but typically responds better to antibiotic therapy. Eosinophilic keratitis, an immune-mediated feline condition, can cause corneal lesions resembling chronic herpes disease but requires different treatment. Corneal sequestrum may develop secondary to herpesvirus but also occurs in uninfected cats. Bacterial keratitis, foreign bodies, and traumatic ulceration can all cause corneal lesions requiring differentiation from viral disease.

Diagnosis confirmation of herpesviral keratoconjunctivitis relies on the combination of compatible clinical findings and, when obtained, positive PCR testing. The characteristic dendritic ulceration pattern, when present, is essentially diagnostic even without laboratory confirmation. History of recurrent eye disease with typical herpesviral presentation strongly suggests the diagnosis. Response to antiviral therapy provides supportive evidence. In research settings, viral isolation or immunofluorescent antibody testing can confirm diagnosis, but these modalities are rarely used clinically. The widespread prevalence of herpesvirus in the cat population means that serologic testing for antibodies has limited diagnostic utility, as most cats will be seropositive regardless of whether current disease is herpesvirus-related.

Emergency and immediate treatment for severe herpesviral keratoconjunctivitis focuses on protecting the cornea and initiating antiviral therapy. If deep corneal ulceration is present, aggressive treatment aims to prevent perforation and preserve the eye. Frequency of medication application is increased, sometimes to every two hours, to maximize therapeutic effect. Atropine may be used to reduce painful ciliary spasm and prevent synechiae formation. An Elizabethan collar is essential to prevent self-trauma from rubbing painful eyes. Cats with severe systemic signs, high fever, or complete anorexia may require hospitalization for supportive care and intensive monitoring.

Medical management of feline herpesviral keratoconjunctivitis involves antiviral medications, supportive care, and often concurrent antibiotic therapy to address secondary bacterial infection. Topical antiviral medications include cidofovir, which requires less frequent application than older antivirals, and trifluridine or idoxuridine, which require more frequent dosing but may be more readily available. Oral antiviral therapy with famciclovir provides systemic antiviral effect and is particularly useful for bilateral or severe disease. Broad-spectrum topical antibiotics such as erythromycin or tobramycin prevent or treat secondary bacterial infection of damaged tissues. The specific treatment protocol is tailored to disease severity and practical considerations.

Surgical options for herpesviral keratoconjunctivitis become necessary when complications develop that cannot be managed medically. Deep or descemetocele corneal ulcers may require conjunctival grafts to provide structural support and blood supply for healing. Corneal sequestra, dark areas of necrotic cornea that develop in some chronic cases, typically require surgical removal through keratectomy. Severe symblepharon, adhesions between the conjunctiva and cornea or eyelids, may require surgical lysis. If the eye becomes irreversibly damaged, blind, and painful despite treatment, enucleation may be necessary to relieve suffering. Referral to a veterinary ophthalmologist is recommended for surgical cases.

Supportive care addresses the cat's overall comfort and nutritional status during active herpesviral disease. Keeping nasal passages clear through gentle cleaning or humidification helps cats smell their food and maintain appetite. Warming food enhances aroma and palatability. Highly palatable foods or appetite stimulants may be needed for cats reluctant to eat. Keeping the eye area clean by gently removing discharge maintains comfort and allows better medication penetration. Stress reduction through environmental modifications supports immune function and healing. Adequate hydration is ensured through wet food feeding or subcutaneous fluids if needed.

Alternative and complementary treatments have been explored for feline herpesvirus with variable evidence for efficacy. L-lysine supplementation has been traditionally recommended based on the theory that it inhibits viral replication by competing with arginine, but recent controlled studies have failed to demonstrate clinical benefit and some suggest it may even be counterproductive. Omega-3 fatty acid supplementation may provide anti-inflammatory support. Probiotics may support immune function during illness. Interferon omega has shown some promise as an immunomodulator. Any complementary approaches should be discussed with the veterinarian to ensure they do not interfere with primary treatment.

Treatment decisions for herpesviral keratoconjunctivitis consider disease severity, patient factors, and practical constraints. Mild cases may be managed with relatively simple protocols, while severe or complicated disease requires intensive therapy. The cost of antiviral medications, particularly topical cidofovir and oral famciclovir, can be significant and affects treatment selection. Owner ability to administer medications multiple times daily influences protocol design. For cats with frequently recurring disease, long-term management strategies including prophylactic antiviral therapy during anticipated stressful periods may be discussed. Expected outcomes vary from complete resolution of acute episodes to chronic management of persistent disease.

Recovery timeline for acute herpesviral keratoconjunctivitis episodes varies with disease severity and treatment response. Mild to moderate conjunctivitis typically improves within the first week of treatment, with substantial resolution by two to three weeks. Corneal ulceration requires longer healing times, with superficial ulcers resolving in one to two weeks and deeper ulcers taking three weeks or longer. Clinical improvement usually precedes complete healing, with cats becoming more comfortable before all lesions fully resolve. Following resolution of acute disease, the virus returns to latency, and the cat remains a carrier with potential for future recurrence.

Post-treatment care for herpesviral keratoconjunctivitis involves completing prescribed medication courses and monitoring for recurrence. Even after clinical signs resolve, continuing antiviral therapy for the recommended duration helps ensure adequate viral suppression. Follow-up examination confirms healing and screens for developing complications. Owners should be educated about the chronic nature of herpesvirus infection and the likelihood of future episodes. Identifying and minimizing known stress triggers helps reduce reactivation frequency. Some veterinarians recommend prophylactic antiviral therapy before anticipated stressful events such as boarding, travel, or surgery.

Prognosis for feline herpesviral keratoconjunctivitis depends on multiple factors including disease severity, response to treatment, and the cat's immune status. Most cats with uncomplicated conjunctivitis or superficial keratitis respond well to treatment and recover fully from individual episodes. However, the lifelong carrier state means recurrence is expected in most cats, though episode frequency typically decreases with age as the immune system matures. Severe corneal disease, particularly with stromal involvement or sequestrum formation, carries more guarded prognosis for visual preservation. Cats with concurrent immunosuppression face more challenging disease management.

Long-term outlook for cats with herpesviral keratoconjunctivitis involves living with a chronic viral infection that may cause intermittent clinical disease. Many cats experience several episodes during the first few years after initial infection, with decreasing frequency thereafter. Some cats have minimal ongoing problems, experiencing only rare, mild recurrences, while others struggle with frequent or chronic disease. Cumulative corneal damage from repeated episodes can lead to permanent visual impairment in severe cases. Quality of life remains good for most cats between episodes, and even cats with frequent recurrences can maintain acceptable comfort with appropriate management. Owner education and preparedness for recurrences are key components of successful long-term management.

Primary prevention of feline herpesviral keratoconjunctivitis centers on reducing viral exposure, though the ubiquity of the virus makes complete prevention challenging. Vaccination against feline herpesvirus, included in core feline vaccination protocols, does not prevent infection but significantly reduces disease severity in vaccinated cats that become infected. Keeping cats indoors and limiting contact with cats of unknown health status reduces exposure risk. New cats should be quarantined and examined before introduction to established households. For catteries and shelters, strict isolation protocols, good sanitation, and appropriate ventilation minimize transmission.

Environmental prevention strategies focus on reducing virus transmission and minimizing reactivation triggers. The virus survives only briefly in the environment and is readily inactivated by common disinfectants, making thorough cleaning effective for environmental decontamination. In multi-cat households, providing adequate resources reduces stress-related reactivation. Maintaining stable environments with minimal changes helps keep latently infected cats from experiencing triggered flares. Good ventilation in housing areas dilutes airborne virus particles. Avoiding overcrowding and maintaining appropriate population density reduces both transmission and stress.

Dietary prevention supports immune function to help cats resist infection and control viral reactivation. Feeding complete, balanced commercial cat foods provides essential nutrients for optimal immune response. Adequate protein intake ensures amino acid availability for immune cell function. While L-lysine supplementation was previously widely recommended, current evidence does not support its efficacy and it is no longer generally advised. Omega-3 fatty acid supplementation may provide anti-inflammatory benefits that support ocular surface health. Maintaining healthy body condition through appropriate feeding supports overall immune competence.

Health maintenance practices help minimize disease impact in exposed cats. Keeping core vaccinations current provides the best available protection against severe disease. Prompt veterinary attention for any eye symptoms allows early treatment of developing episodes. Regular wellness examinations monitor overall health and identify any factors that might increase susceptibility to viral reactivation. Managing concurrent health problems maintains immune function. For known carrier cats, developing a plan with the veterinarian for managing anticipated flares improves response time when episodes occur.

Early intervention when disease develops limits episode severity and tissue damage. Owners of cats with known herpesvirus carrier status should learn to recognize the earliest signs of reactivation, including subtle squinting, increased tearing, or mild redness. Having antiviral medication available for prompt initiation of therapy at the first sign of recurrence can significantly reduce episode severity and duration. Any observed eye abnormalities in susceptible cats warrant immediate veterinary contact rather than watchful waiting. Early aggressive treatment of acute episodes minimizes cumulative corneal damage from repeated disease cycles.

Daily management of cats with recurrent herpesviral keratoconjunctivitis involves maintaining awareness of their carrier status and being prepared for episodic flares. During quiescent periods, no specific daily interventions may be needed beyond general health maintenance. Observing the cat's eyes as part of normal interaction helps detect early signs of reactivation. Keeping antiviral medications on hand allows prompt treatment initiation when needed. Maintaining a record of flare frequency, triggers, and treatment response helps identify patterns and optimize management over time. Consistent daily routines help minimize stress that could trigger viral reactivation.

Home environment optimization supports cats prone to herpesviral flares. Minimizing stressors such as loud noises, frequent visitors, conflict with other pets, and environmental changes reduces reactivation triggers. Providing adequate resources in multi-cat households, including multiple food stations, water sources, and litter boxes, prevents competition-related stress. Creating safe spaces where cats can retreat when feeling overwhelmed supports emotional wellbeing. Maintaining consistent schedules for feeding, play, and interaction provides the stability that helps keep stress levels low. Air quality maintenance through filtration and avoiding aerosols protects already vulnerable ocular surfaces.

Maintaining quality of life for cats with chronic herpesviral eye disease involves balancing disease management with normal activities. Between episodes, cats can and should engage in normal play, exercise, and social interaction. Mental stimulation through environmental enrichment, food puzzles, and interactive play maintains psychological health. During active flares, reducing activity expectations while providing comfort and supportive care helps cats through the episode. Even cats with chronic low-grade disease can maintain good quality of life with appropriate management. The goal is to minimize episode frequency and severity while maximizing comfort and normal function.

Monitoring and ongoing care for herpesviral keratoconjunctivitis involves vigilance for flares and regular professional assessment. Owners should check their cat's eyes daily, watching for early signs of redness, squinting, discharge, or behavior changes suggesting discomfort. Documenting episodes including potential triggers, symptom progression, and treatment response provides valuable information for optimizing long-term management. Regular veterinary examinations, at least annually for cats with infrequent problems and more often for those with frequent disease, allow professional assessment of eye health and treatment plan adjustments. Any changes in flare frequency, severity, or treatment response should prompt veterinary consultation.

Caregiver support resources help owners manage the challenges of living with a chronically infected cat. Understanding that herpesvirus is extremely common and not a reflection of owner failure provides perspective. Learning to recognize early flare signs and respond promptly builds confidence. Connecting with other owners of herpes-positive cats through online communities provides emotional support and practical tips. Discussing concerns about treatment costs, frequency of flares, or long-term prognosis with the veterinary team allows problem-solving and realistic expectation-setting. Recognizing that many cats with herpesvirus live normal, happy lives with only occasional management needs provides reassurance.

Feline herpesviral keratoconjunctivitis does not demonstrate breed predisposition, as susceptibility depends on viral exposure and immune factors rather than genetic breed characteristics. The virus affects cats of all breeds equally when exposure occurs, and no breed has been shown to have significantly elevated or reduced risk. Persian, Himalayan, and other brachycephalic breeds may appear more commonly affected in some clinical populations, but this likely reflects their anatomical predisposition to eye problems in general rather than specific herpesvirus susceptibility. The flat facial structure of these breeds may cause more severe or prolonged clinical signs when infection occurs.

Cats at elevated risk for herpesviral keratoconjunctivitis include those in environments with high exposure potential. Shelter and rescue cats face dramatically elevated risk due to crowded conditions, stress, and high population turnover facilitating virus transmission. Cattery cats experience similar risk factors. Kittens are particularly vulnerable due to immature immune systems and the waning of maternal immunity. Cats in multi-cat households have increased exposure opportunity compared to single-cat homes. Outdoor cats or those with outdoor access may encounter infected cats in the community. Cats with compromised immune systems from FIV, FeLV, or other conditions experience more severe and persistent disease.

Screening recommendations for herpesviral keratoconjunctivitis apply primarily to cats entering new environments or breeding programs. Examination of new cats before introduction to existing households helps identify active disease that should be treated and isolated before exposure of residents. For breeding catteries, while testing cannot identify all carriers, evaluation for active disease reduces transmission risk. Cats with history of recurrent eye disease should have herpesvirus status documented for future reference. Routine screening of healthy cats is not generally recommended given the high prevalence of latent infection in the general population and the lack of effective treatments for latent virus.

Feline herpesviral keratoconjunctivitis commonly co-occurs with other manifestations of feline herpesvirus infection. Upper respiratory disease, characterized by sneezing, nasal discharge, and congestion, frequently accompanies ocular signs during primary infection and may recur with eye flares. Oral ulceration can develop during acute infection, contributing to anorexia. Dermatitis, particularly affecting the face and nasal area, occurs in some cases. Chronic rhinosinusitis may persist long-term in some infected cats. Managing the complete syndrome requires attention to all affected systems, with supportive care for respiratory and oral symptoms complementing specific eye treatment.

Conditions with symptoms similar to herpesviral keratoconjunctivitis require differentiation for appropriate treatment. Chlamydophila felis causes conjunctivitis that may resemble mild herpes disease but typically produces less corneal involvement and responds to specific antibiotic therapy. Eosinophilic keratitis creates corneal lesions that may be confused with chronic herpes disease but requires corticosteroid therapy that would worsen herpesvirus infection. Corneal sequestrum may develop secondary to herpes but also occurs in uninfected cats. Mycoplasma conjunctivitis produces discharge and discomfort mimicking mild herpes disease. Accurate differentiation through examination and appropriate testing guides proper treatment selection.

Potential complications of herpesviral keratoconjunctivitis include progressive corneal damage and chronic ocular surface disease. Stromal keratitis, deeper corneal inflammation with immune-mediated components, can develop in recurrent cases. Corneal sequestrum, a dark area of necrotic cornea unique to cats, commonly develops secondary to herpesvirus infection. Symblepharon, adhesions between the conjunctiva and cornea or between conjunctival surfaces, can cause permanent functional problems. Keratoconjunctivitis sicca may develop from herpesvirus damage to lacrimal structures. Deep corneal ulceration can progress to descemetocele or perforation if not treated aggressively. Early aggressive treatment and appropriate follow-up care minimize complication risk.